Last reviewed 2026-05-22 · How we verify

Rouvastatin calcium

Alison Morris · Phase 1 active Small molecule ✓ Verified May 2026 Quality 0/100

Rouvastatin calcium is a Small molecule drug developed by Alison Morris. It is currently in Phase 1 development. Also known as: Crestor.

Rouvastatin calcium is a small molecule medication. It has been studied in clinical trials for conditions related to HIV seropositivity, including pulmonary and cardiac complications.

Likelihood of approval

9.6% vs 9.6% industry baseline

If approved by FDA: likely 2033–2036

Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 1 → approval rate +9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2033–2036	—
EMA	EU	2034–2037	+0.7 yr
MHRA	GB	2034–2037	+0.7 yr
Health Canada	CA	2034–2038	+0.9 yr
TGA	AU	2034–2038	+1.2 yr
PMDA	JP	2034–2038	+1.5 yr
NMPA	CN	2035–2039	+2.3 yr
MFDS	KR	2034–2038	+1.4 yr
CDSCO	IN	2034–2039	+1.8 yr
ANVISA	BR	2035–2039	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	Rouvastatin calcium
Also known as	Crestor
Sponsor	Alison Morris
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center (EARLY_PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Rouvastatin calcium CI brief — competitive landscape report
Rouvastatin calcium updates RSS · CI watch RSS
Alison Morris portfolio CI

Frequently asked questions about Rouvastatin calcium

What is Rouvastatin calcium?

Rouvastatin calcium is a Small molecule drug developed by Alison Morris.

Who makes Rouvastatin calcium?

Rouvastatin calcium is developed by Alison Morris (see full Alison Morris pipeline at /company/alison-morris).

Is Rouvastatin calcium also known as anything else?

Rouvastatin calcium is also known as Crestor.

What development phase is Rouvastatin calcium in?

Rouvastatin calcium is in Phase 1.

Manufacturer: Alison Morris — full pipeline
Also known as: Crestor

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing